Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine or remifentanil infusion effects on end-tidal sevoflurane during laparoscopic cholecystectomy
PACTR201611001829308Not yet recruiting
- Sponsor
- Tanta University Hospitals
- Start
- Oct 2016
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Trial of dexmedetomidine, remifentanil and sevoflurane in gallbladder disease (3 arms), sponsored by Tanta University Hospitals. Primary endpoints: End-tidal carbon dioxide concentration and End-expiratory sevoflurane concentration. Planned start Oct 2016; status: not yet recruiting.
02
Drugs
dexmedetomidineremifentanilsevoflurane
03
Conditions
gallbladder disease
Beyond the preview
Go deeper on PACTR201611001829308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201611001829308.